NAMI Corp. (NASDAQ:NAMI – Get Free Report)’s share price traded down 4.6% on Monday . The company traded as low as $0.93 and last traded at $0.93. 24,746 shares traded hands during trading, a decline of 35% from the average session volume of 38,120 shares. The stock had previously closed at $0.9750.
Analyst Ratings Changes
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of NAMI in a research note on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has an average rating of “Sell”.
View Our Latest Analysis on NAMI
NAMI Stock Down 4.6%
NAMI announced that its board has approved a stock buyback plan on Wednesday, October 22nd that permits the company to buyback $0.00 in shares. This buyback authorization permits the company to buy shares of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s leadership believes its stock is undervalued.
Institutional Investors Weigh In On NAMI
A hedge fund recently bought a new stake in NAMI stock. XTX Topco Ltd acquired a new stake in NAMI Corp. (NASDAQ:NAMI – Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 26,778 shares of the company’s stock, valued at approximately $75,000.
About NAMI
Jinxin Technology Holding Co engages in the provision of digital content services. The company was founded in August 2015 and is headquartered in Shanghai, China.
See Also
- Five stocks we like better than NAMI
 - How to Calculate Retirement Income: MarketBeat’s Calculator
 - Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
 - The How And Why of Investing in Oil Stocks
 - The Best Local Butchers for Thanksgiving [2025 Survey]
 - The 3 Best Retail Stocks to Shop for in August
 - $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
 
Receive News & Ratings for NAMI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NAMI and related companies with MarketBeat.com's FREE daily email newsletter.
